Immunomedics Inc
IMMU
IMMU was delisted on the 22nd of October, 2020.
0 hedge funds and large institutions have $0 invested in Immunomedics Inc in 2020 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 403 closing their positions.
100% less funds holding
Funds holding: 408 → 0 (-408)
100% less funds holding in top 10
Funds holding in top 10: 68 → 0 (-68)
100% less capital invested
Capital invested by funds: $17B → $0 (-$17B)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 403
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACA
Avoro Capital Advisors
New York
|
-$2.23B |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.54B |
| 3 |
BlackRock
New York
|
-$1.14B |
| 4 |
HI
HBK Investments
Dallas,
Texas
|
-$553M |
| 5 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$498M |
IMMU Hedge Fund Activity: Q4 2020 in Review
0 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Immunomedics Inc (IMMU) for Q4 2020, worth a combined $0 — down 100% from $17B a quarter earlier.
Sellers outnumbered buyers: 403 funds closed out of IMMU and 0 opened new positions — a net loss of 403 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Avoro Capital Advisors, exiting entirely with an estimated $2.23B sold.
- 0 institutional investors held Immunomedics Inc (IMMU) as of Q4 2020, down from 408 in Q3 2020.
- Funds reported $0 of Immunomedics Inc stock for Q4 2020, down 100% quarter-over-quarter.
- 0 funds opened new Immunomedics Inc positions in Q4 2020 and 403 closed out, a net change of -403 holders.
- The largest Immunomedics Inc seller in Q4 2020 was Avoro Capital Advisors, an estimated $2.23B sold.
Based on aggregated 13F filings for Q4 2020.